Vaginal supplementation of high concentration Oxygen for the treatment of vaginal infections: a pilot, controlled trial
European Gynecology & Obstetrics · 22.05.2025 · 7 (1)
DOI: 10.53260/ego.257016 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Gynecology & Obstetrics, online erschienen am 22.05.2025. Verfasst von Fabio Facchinetti und 5 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Vaginal discomfort (VD) due to infections remains a challenge in clinical practice. Since many microbial agents grow in anaerobic conditions, a novel approach using oxygen supply has been proposed.
Objective
The aim of this pilot study was to verify the clinical effects of vaginal oxygen insufflation in women presenting with vaginal infections.
Methods
Fertile age women with a diagnosis of vaginal infections of different etiology were enrolled in a randomized, controlled, open label, monocentric trial. Women with vulvo-vaginal atrophy, amenorrhea since at least 3 months and exposure to antibiotics in the previous 30 days were excluded. Gynecological examination and vaginal swabs were performed. Women were randomized to 3 treatment groups. Group A received vaginal normobaric, high concentration oxygen supply (O2 concentration >95%, 3 lt/min for 20 minutes), twice/week for 2 weeks; group B received vaginal oxygen as Group A added to a targeted antibiotic or antimycotic treatment for 5-7 days; Group C received only the targeted antibiotic or antimycotic treatment for 5-7 days. Subjects rated vaginal discharges, vulvovaginal itching/burning and dyspareunia before and 10-14 days after end of treatment on a Likert scale. VD score was obtained with the sum of single symptoms.
Results
Out of 36 randomized women 32 were analyzed. Bacterial vaginosis (n=14), candidiasis (n=7) and aspecific vaginal infections (n=11) were equally distributed among groups. Baseline VD, as well as single symptom scores were not different among groups. At the end of the treatments, the VD score was significantly reduced by 89.2 ± 7.1% in Group A, by 85.1 ± 10.1% in group C and to a lesser extent by 52.8 ± 9.2% in group B, with significant reduction occurred in single symptoms.
Conclusions
These findings demonstrate that the vaginal supply of high concentration oxygen has proven efficacy in patients presenting with vaginal infections.
Zitieren
APA
Facchinetti, F., Longo, M., Danieli, A., Melis, B., Garoia, F., & Bergamini, E. (2025). Vaginal supplementation of high concentration Oxygen for the treatment of vaginal infections: a pilot, controlled trial. European Gynecology & Obstetrics, 7(1). https://doi.org/10.53260/ego.257016
Vancouver
Facchinetti F, Longo M, Danieli A, Melis B, Garoia F, Bergamini E. Vaginal supplementation of high concentration Oxygen for the treatment of vaginal infections: a pilot, controlled trial. European Gynecology & Obstetrics. 2025;7(1). doi:10.53260/ego.257016
BibTeX
@article{Facchinetti2025,
author = {Facchinetti, Fabio and Longo, Maria and Danieli, Alessandra and Melis, Beatrice and Garoia, Flavio and Bergamini, Ezio},
title = {Vaginal supplementation of high concentration Oxygen for the treatment of vaginal infections: a pilot, controlled trial},
journal = {European Gynecology & Obstetrics},
year = {2025},
volume = {7},
number = {1},
doi = {10.53260/ego.257016}
}
EUVIMED